Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.545
-0.022 (-3.81%)
At close: Dec 20, 2024, 4:00 PM
0.560
+0.015 (2.75%)
After-hours: Dec 20, 2024, 7:29 PM EST
MTNB Market Cap
MTNB has a market cap or net worth of $2.77 million as of December 20, 2024. Its market cap has decreased by -94.63% in one year.
Market Cap
2.77M
Enterprise Value
-4.95M
1-Year Change
-94.63%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $2.77M, a decrease of -98.76%. That is a compound annual growth rate of -43.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 2.80M | -94.04% |
Dec 29, 2023 | 47.00M | -56.64% |
Dec 30, 2022 | 108.40M | -50.37% |
Dec 31, 2021 | 218.40M | -19.41% |
Dec 31, 2020 | 271.00M | -26.64% |
Dec 31, 2019 | 369.40M | 452.17% |
Dec 31, 2018 | 66.90M | -37.94% |
Dec 29, 2017 | 107.80M | -51.77% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Entero Therapeutics | 2.94M |
Windtree Therapeutics | 2.92M |
ZyVersa Therapeutics | 2.91M |
LogicMark | 2.88M |
ENDRA Life Sciences | 2.88M |
Scinai Immunotherapeutics | 2.87M |
iSpecimen | 2.85M |
Regional Health Properties | 2.69M |